• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS PREMIER¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493952816250
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 12/20/2016
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the right coronary artery.A 2.50x16mm promus premier¿ drug-eluting stent was selected for use to treat a lesion.However, when the device was loaded onto the wire, the device broke.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr: the stent delivery system was returned for analysis.A visual and tactile examination of the midshaft section found the midshaft broken at 4.2cm distal from the hypotube to the midshaft bond.The outer extrusion, inner lumen and bi-component bond showed no signs of damage or strain.A visual and tactile examination found several hypotube kinks across the length of the shaft.This type of damage is consistent with excessive force being applied to the delivery system.A visual examination of the crimped stent found no issues with the crimped stent.There were no signs of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set equidistant between the proximal and distal markerbands.The crimped stent outer diameter was measured and reading is within the specification.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.The bumper tip of the device showed no signs of damage.No other issues were identified during product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is considered handling damage as the event occurred without direct patient contact.(b)(4).
 
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the right coronary artery.A 2.50x16mm promus premier¿ drug-eluting stent was selected for use to treat a lesion.However, when the device was loaded onto the wire, the device broke.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER¿
Common Device Name
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key6255899
Report Number2134265-2016-12594
Device Sequence Number16392207
Product Code NIQ
UDI-Device Identifier08714729844716
UDI-Public(01)08714729844716(17)20170423(10)18577286
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P110010
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date (Section B) 12/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/23/2017
Device Model NumberH7493952816250
Device Catalogue Number39528-1625
Device Lot Number18577286
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/05/2017
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 12/20/2016
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date01/17/2017
Supplement Report FDA Received Date02/23/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age77 YR
-
-